A new study suggests that the use of 5D scans for the treatment of cancer is getting a lot more mainstream.
Researchers at the University of Washington and the University at Buffalo recently released a study looking at 5D scanning as an effective treatment for colorectal cancer.
“We found that there are already clinical trials that show the use and benefits of 5d scanners for colitis and other cancers,” said Dr. Sarah Miller, an associate professor of medicine at UW.
The study focused on the use in the treatment and prevention of colon cancer.
5D imaging is a type of digital imaging technology that allows for the rapid, precise, and wide-field imaging of cells.
The technique is usually used for cancer diagnosis and treatment.
Miller and her team analyzed data from the National Health Interview Survey.
The survey is a nationally representative survey of more than 11,000 Americans conducted every two years.
It was collected in December of 2011.
The results of the study are expected to be published in an upcoming issue of the American Journal of Epidemiology.
Miller said 5D scan technology is gaining acceptance as a treatment for cancers of the colon and rectum.
“I think we have to look at what the data is, and what we’re doing with it, and I think the results are pretty good,” she said.
“It’s not something that is really widely used yet.
The 5D scanner is still in its infancy,” said Miller.
“It’s an early stage of the technology.”
Miller said the study found that people were using 5D for a variety of different cancers, including cancer of the breast, prostate, liver, pancreas, and lung.
In fact, a significant number of people who are currently receiving treatment for cancer are using 5Ds for these conditions.
The new study also found that the rate of patients receiving treatment with 5Ds dropped by about 40 percent.
The researchers say the data indicates that the treatment is a cost-effective treatment for some types of cancers.
“One of the key things to remember is that the cost per patient is a very, very small part of the total cost of the treatment,” said Ryan Schloss, an assistant professor of pathology and molecular pathology at UW and a member of the research team.
Schloss is a co-author of the new study.
“So the number of patients getting this treatment is very small, and they are using it for a very different cancer than they were before,” he said.
For some people, the cost of a colonoscopy is very low, but if they have a chronic illness like colitis or cancer of any kind, that may be very expensive, he said, adding that the more advanced technology is more effective at treating chronic illnesses like cancer.
Schlipps study also looked at whether or not 5D can be used for colon cancer treatment in people with certain chronic illnesses.
He said he believes there are some potential benefits to 5D, but it needs more studies.
“The bottom line is that we don’t know what the safety profile is yet, but we know there are potential risks and we know that 5D is more sensitive to cancer risk factors,” he explained.
“And so we need to do more clinical trials before we can say that that’s the way it works.”
Miller believes the study could also help other types of cancer.
“If we can get to that point where we know the safety is safe, then that’s going to be an exciting opportunity to try and use it in a way that is beneficial to all of us,” she added.
Miller added that there have been many clinical trials involving 5D and other imaging devices for other cancers, and she said she is confident that these studies will show the benefits of the scanning technology for other types as well.
“In my experience, the data has been very promising so far, and it’s a little bit early to say whether or no we have a significant benefit for other diseases,” she concluded.
“But I think that the data looks very promising and it looks like there are promising uses for 5D,” she explained.
Follow Jill on Twitter and Google+.